Delgen Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $50K

  • Investors
  • 4

Delgen Biosciences General Information

Description

Operator of a biotechnology firm intended to enhance future precision medicine. The company innovates in biocompatible nanomaterials and develops drug delivery technologies for creating ophthalmic drugs, enabling clients to find drug delivery vehicles with many features at the molecular level, making them an ideal vehicle for delivering protein drugs with precision, duration, and controlled release.

Contact Information

Website
delgenbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 408 Ironwoods Drive
  • Chapel Hill, NC 27516-8726
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Corporate Office
  • 408 Ironwoods Drive
  • Chapel Hill, NC 27516-8726
  • United States

Delgen Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delgen Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 13-Mar-2025 $50K Completed Startup
3. Grant 01-Jan-2023 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Delgen Biosciences’s complete valuation and funding history, request access »

Delgen Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delgen Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
KickStart Venture Services Accelerator/Incubator
National Institutes of Health Government
University of North Carolina University
Kickstart Innovation Accelerator/Incubator
To view Delgen Biosciences’s complete investors history, request access »

Delgen Biosciences FAQs

  • When was Delgen Biosciences founded?

    Delgen Biosciences was founded in 2020.

  • Where is Delgen Biosciences headquartered?

    Delgen Biosciences is headquartered in Chapel Hill, NC.

  • What is the size of Delgen Biosciences?

    Delgen Biosciences has 2 total employees.

  • What industry is Delgen Biosciences in?

    Delgen Biosciences’s primary industry is Biotechnology.

  • Is Delgen Biosciences a private or public company?

    Delgen Biosciences is a Private company.

  • What is Delgen Biosciences’s current revenue?

    The current revenue for Delgen Biosciences is .

  • How much funding has Delgen Biosciences raised over time?

    Delgen Biosciences has raised $50K.

  • Who are Delgen Biosciences’s investors?

    KickStart Venture Services, National Institutes of Health, University of North Carolina, and Kickstart Innovation have invested in Delgen Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process